PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT

PMV Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a 1.62M 1.62M 1.62M 1.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
32K 372K 734K 1.09M 1.45M 1.45M 1.17M 969K 755K 565K 650K 897K 1.16M 1.05M 967K 560K 150K 79K
Gross Profit
-32K -372K -734K 525K 167K 170K 450K -969K -755K -565K -650K -897K -1.16M -1.05M -967K -560K -150K -79K
Operating Income
-91.5M -88.79M -85.45M -79.18M -76.92M -76.87M -80.13M -82.39M -82.14M -79.9M -77.04M -74.35M -70.07M -65.24M -58.29M -50.32M -43.93M -38.96M
Interest Income
6.59M 7.7M 10.65M 11.53M 11.9M 11.8M 11.17M 9.8M 7.94M 5.85M 3.75M 2.06M 1.04M 550K 449K 391K 329K 373K
Pretax Income
-82.99M -79.17M -74.81M -67.56M -65.05M -65.1M -68.96M -72.55M -74.14M -74.02M -73.33M -72.34M -69.09M -64.66M -57.82M -49.92M -43.69M -38.78M
Net Income
-80.87M -60.88M -58.71M -51.47M -48.88M -65.1M -66.61M -70.18M -71.77M -71.64M -73.3M -72.33M -69.11M -64.68M -57.85M -49.94M -43.69M -38.79M
Selling & General & Admin
24.94M 26.01M 26.92M 21.04M 22.14M 22.88M 24.25M 24.86M 24.53M 24.68M 25.05M 25.22M 25.45M 24.41M 21.8M 19.82M 16.59M 13.48M
Research & Development
66.52M 62.41M 57.79M 57.05M 53.69M 53.28M 55.52M 57.53M 57.61M 55.23M 51.99M 49.13M 44.63M 40.83M 36.49M 30.51M 27.34M 25.48M
Other Expenses
n/a -17K -18K -39K -35K -24K 4K 45K 54K 29K -39K -52K -62K 32K 21K 14K 11K -91K
Operating Expenses
91.47M 88.42M 84.71M 78.09M 75.83M 76.15M 79.77M 82.39M 82.14M 79.9M 77.04M 74.35M 70.07M 65.24M 58.29M 50.32M 43.93M 38.96M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
91.5M 88.79M 85.45M 79.18M 76.92M 76.87M 80.13M 82.39M 82.14M 79.9M 77.04M 74.35M 70.07M 65.24M 58.29M 50.32M 43.93M 38.96M
Income Tax Expense
-2.12M -18.3M -16.1M -16.1M -16.17M 3K -2.35M -2.37M -2.38M -2.38M -27K 14K 42K -69K -67K -89K -105K 8K
Shares Outstanding (Basic)
52.01M 51.95M 51.57M 51.57M 51.48M 51.45M 51.45M 49.05M 45.81M 45.77M 45.7M 45.62M 45.57M 45.47M 45.3M 45.3M 45.07M 44.79M
Shares Outstanding (Diluted)
52.01M 51.95M 51.57M 51.57M 51.48M 51.45M 51.45M 49.05M 45.81M 45.77M 45.7M 45.62M 45.57M 45.47M 45.3M 45.3M 45.07M 44.79M
EPS (Basic)
-0.75 -0.36 -0.32 -1 -0.97 -1.33 -1.45 -1.56 -1.62 -1.62 -1.61 -1.6 -1.53 -1.44 -1.29 -1.16 -1.06 -0.96
EPS (Diluted)
-0.75 -0.36 -0.32 -1 -0.97 -1.33 -1.45 -1.56 -1.62 -1.62 -1.61 -1.6 -1.53 -1.44 -1.29 -1.16 -1.06 -0.96
EBITDA
-89.38M -88.01M -83.63M -77.04M -74.8M -74.75M -78.88M -81.42M -81.45M -79.5M -76.73M -74.03M -69.75M -64.93M -57.99M -50.03M -43.64M -38.66M
EBIT
-89.83M -88.79M -85.45M -79.18M -76.92M -76.87M -80.13M -82.39M -82.14M -79.9M -77.04M -74.35M -70.07M -65.24M -58.29M -50.32M -43.93M -38.96M
Depreciation & Amortization
479K 819K 1.14M 1.46M 1.45M 1.45M 1.17M 969K 755K 565K 650K 897K 1.16M 1.05M 967K 621K 286K 303K